0
0

PBM Transparency in Prescription Drug Costs Act

10/28/2022, 1:46 AM

Congressional Summary of HR 5304

PBM Transparency in Prescription Drug Costs Act

This bill requires group health plans or the pharmacy benefits manager (PBM) for the plans to periodically report certain prescription drug pricing and utilization data; it also requires PBMs to pass on to health plans all rebates and discounts received from drug manufacturers.

Current Status of Bill HR 5304

Bill HR 5304 is currently in the status of Bill Introduced since December 4, 2019. Bill HR 5304 was introduced during Congress 116 and was introduced to the House on December 4, 2019.  Bill HR 5304's most recent activity was Referred to the Subcommittee on Health. as of December 5, 2019

Bipartisan Support of Bill HR 5304

Total Number of Sponsors
1
Democrat Sponsors
1
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
1
Democrat Cosponsors
0
Republican Cosponsors
1
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HR 5304

Primary Policy Focus

Health

Potential Impact Areas

- Business records
- Employee benefits and pensions
- Health care costs and insurance
- Health information and medical records
- Prescription drugs
- Right of privacy

Alternate Title(s) of Bill HR 5304

PBM Transparency in Prescription Drug Costs Act
To amend title XXVII of the Public Health Service Act to require health plan oversight of pharmacy benefit manager services, and for other purposes.
PBM Transparency in Prescription Drug Costs Act

Comments